| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $129,934,156 ) (Continued on the next page) |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD112302 | Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children | 001 | 4 | NIH | 3/23/2026 | $0 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL166266 | Heterogeneity of bone marrow cavities shaping the hematopoietic microenvironment | 001 | 3 | NIH | 3/24/2026 | $21,384 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R34NS139993 | Beyond Barriers: Leveraging Community Expertise for Improved Neurological Health among U.S. Resettled Refugees | 000 | 2 | NIH | 4/3/2026 | $246,916 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K08HL168238 | Advancing the clinical actionability of polygenic scores for coronary artery disease | 000 | 3 | NIH | 4/3/2026 | $170,323 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23MH138987 | Electroencephalographic Measures for the Diagnosis and Monitoring of Catatonia. | 000 | 1 | NIH | 4/3/2026 | $197,614 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R13EB039477 | Endorsed ISMRM Workshop on MRI of Neuromodulation | 000 | 1 | NIH | 4/3/2026 | $10,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R03DA064903 | Uncovering Patterns in the Evolving Drug Supply to Detect Emerging Overdose Trends Using Machine Learning | 001 | 1 | NIH | 4/3/2026 | -$62,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01AG072046 | Optical probe and instrumentation development for in vivo near-infrared fluorescence imaging of Alzheimer's disease | 000 | 5 | NIH | 1/21/2026 | $127,320 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA269672 | Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma | 000 | 5 | NIH | 3/6/2026 | $379,634 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH140004 | Enhancing Suicide Risk Detection through Computer Vision: a Novel Approach to Tissue Damage Analysis in Emergency Care | 000 | 1 | NIH | 3/6/2026 | $839,023 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K99CA296772 | Elucidating Thiol Reductive Stress in Lung Cancer Growth and Metastasis | 000 | 2 | NIH | 1/21/2026 | $126,117 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS146113 | Non-Invasive Vagus Nerve Stimulation in Subarachnoid Hemorrhage | 000 | 1 | NIH | 1/21/2026 | $511,402 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH139643 | Characterizing intracortical feedforward and feedback sensory processes in ASD | 000 | 1 | NIH | 3/27/2026 | $824,728 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R37CA288343 | A compact beam delivery system enabling ultra-fast dose delivery for upright proton therapy | 000 | 3 | NIH | 3/27/2026 | $487,665 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG086433 | New epigenetic inhibitors for Alzheimer's disease treatment | 000 | 3 | NIH | 3/3/2026 | $806,956 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01AG088184 | Profiling and forecasting individual unique progression in ADRD using machine learning | 000 | 2 | NIH | 4/3/2026 | $129,330 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23MH135748 | Developing and piloting a multilevel intervention to address syndemics in people with HIV | 000 | 3 | NIH | 4/3/2026 | $158,957 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS130119 | Late-onset Unexplained Epilepsy as a Risk Factor for Dementia | 000 | 3 | NIH | 3/6/2026 | $2,773,016 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | DP2AG082342 | The inactive X: discovering sex genes that influence female vulnerability to Alzheimer's disease | 000 | 2 | NIH | 1/21/2026 | $893,700 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS134799 | Mechanisms of Chronic Blood-Brain Barrier Dysfunction after Traumatic Brain Injury | 001 | 2 | NIH | 3/18/2026 | $40,410 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA129933 | Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells | 000 | 19 | NIH | 3/19/2026 | $420,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23DK135798 | REACH-Es: Adapting a digital health tool to improve diabetes medication adherence among Latino adults | 000 | 4 | NIH | 3/19/2026 | $195,907 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23HD110597 | Resilient Families (R-FAM): A dyadic resiliency intervention for parents of babies in neonatal intensive care | 000 | 4 | NIH | 3/19/2026 | $169,204 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA289485 | Analyzing DNA replication and damage vulnerability in IDH mutant glioma | 000 | 3 | NIH | 3/19/2026 | $401,140 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS124679 | Preventing and Reversing Mitochondrial Leigh Syndrome with Hypoxia | 001 | 5 | NIH | 3/18/2026 | $49,611 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS126337 | Re-Wiring the Human Brain | 000 | 5 | NIH | 3/30/2026 | $684,129 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AR043369 | MITF from control of pigmentation to melanoma risk | 000 | 30 | NIH | 3/30/2026 | $484,419 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | P41EB015903 | Center for Biomedical OCT Research and Translation | 000 | 15 | NIH | 3/31/2026 | $1,259,558 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG087790 | Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's and Related Dementias among people with HIV in Uganda | 002 | 1 | NIH | 3/28/2026 | $112,527 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R35HL176359 | Macrophages in Cardiovascular Health | 001 | 2 | NIH | 3/31/2026 | $33,833 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DA054145 | Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation with Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment | 000 | 3 | NIH | 3/31/2026 | $763,679 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG082223 | Identifying microscopic vasculature within entorhinal cortex in healthy aging and its proximity to pathology profiles in Alzheimer's disease | 000 | 2 | NIH | 3/30/2026 | $699,509 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA293063 | Pancreatic cancer patient-derived xenograft tumors for translational studies in precision cancer medicine | 000 | 2 | NIH | 3/30/2026 | $654,197 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD112302 | Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children | 002 | 4 | NIH | 4/2/2026 | $259,027 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R00HL169733 | Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease | 000 | 3 | NIH | 4/2/2026 | $249,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD102616 | Brainstem Arousal Network in Human Consciousness: Healthy development vs SIDS | 001 | 5 | NIH | 4/2/2026 | $69,747 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01EB028250 | Mitigation of peripheral nerve stimulation (PNS) in MRI | 000 | 6 | NIH | 4/1/2026 | $604,963 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG083759 | Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models | 000 | 3 | NIH | 4/1/2026 | $825,292 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01HL173622 | Predicting ARDS trajectory with deep generative models of CT images | 000 | 2 | NIH | 3/20/2026 | $145,159 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI170189 | Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection | 000 | 5 | NIH | 4/2/2026 | $471,626 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA262805 | Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer | 000 | 5 | NIH | 3/20/2026 | $711,990 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23DK128567 | Personalizing Therapies for Acute Kidney Injury in Cirrhosis | 000 | 5 | NIH | 4/2/2026 | $196,169 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23DK140642 | Patient-Reported Outcome Measure (PROM) Utilization to Advance Patient Centered CKD Care | 001 | 2 | NIH | 4/1/2026 | $197,474 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32AG099362 | A Novel Mechanism of Autophagic Degradation in Cellular Senescence | 001 | 1 | NIH | 4/1/2026 | $1,260 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH124694 | Alignment of cortical development trajectories with emergent dimensional psychopathology and related risk factors among adolescents in the ABCD Study | 000 | 7 | NIH | 3/24/2026 | $415,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG082331 | Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat | 000 | 4 | NIH | 3/26/2026 | $830,969 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS134597 | Development of Real-World Motor Outcome Measures in Ataxia-Telangiectasia | 000 | 3 | NIH | 3/25/2026 | $624,776 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U01MH136059 | JASPer-MH: Jointly Assessed Scalable Phenotypes for Mental Health | 000 | 3 | NIH | 3/25/2026 | $2,109,289 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA283214 | Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation | 000 | 3 | NIH | 3/23/2026 | $604,063 |
|
